Statistics

Total Visits

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study95

Select a period of time:

Number of views in the range

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study51

Views

Views
March 202514
April 20255
May 20250
June 20253
July 202527
August 20251
September 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil15
Singapore12
Ecuador1
Spain1
France1
Hong Kong1
Jamaica1
Mexico1
Nigeria1
 

Top cities views

Views
São Paulo2
Abuja1
Arlington1
Bauru1
Bressuire1
Celaya1
Charleston1
Council Bluffs1
Dallas1
Fortaleza1